166 related articles for article (PubMed ID: 32408396)
21. HPV post-infection microenvironment and cervical cancer.
Yuan Y; Cai X; Shen F; Ma F
Cancer Lett; 2021 Jan; 497():243-254. PubMed ID: 33122098
[TBL] [Abstract][Full Text] [Related]
22. Burden, trends, and risk factors of esophageal cancer in China from 1990 to 2017: an up-to-date overview and comparison with those in Japan and South Korea.
Yang S; Lin S; Li N; Deng Y; Wang M; Xiang D; Xiang G; Wang S; Ye X; Zheng Y; Yao J; Zhai Z; Wu Y; Hu J; Kang H; Dai Z
J Hematol Oncol; 2020 Nov; 13(1):146. PubMed ID: 33138852
[TBL] [Abstract][Full Text] [Related]
23. Identification of a Novel Glycolysis-Related Gene Signature for Predicting Breast Cancer Survival.
Zhang D; Zheng Y; Yang S; Li Y; Wang M; Yao J; Deng Y; Li N; Wei B; Wu Y; Zhu Y; Li H; Dai Z
Front Oncol; 2020; 10():596087. PubMed ID: 33489894
[TBL] [Abstract][Full Text] [Related]
24. Identification of an immune signature to predict poor clinical outcome in cervical cancer.
Yan W; Jin H; Zhang X; Long S; Xia Q; Meng D; Ding B; Li D; Ma J; Cao J; Wang S
Epigenomics; 2021 Jun; 13(11):891-907. PubMed ID: 33955785
[No Abstract] [Full Text] [Related]
25. The use of host cell DNA methylation analysis in the detection and management of women with advanced cervical intraepithelial neoplasia: a review.
Kremer WW; Steenbergen R; Heideman D; Kenter GG; Meijer C
BJOG; 2021 Feb; 128(3):504-514. PubMed ID: 32619334
[TBL] [Abstract][Full Text] [Related]
26. Potential role of microRNAs in the treatment and diagnosis of cervical cancer.
Shen S; Zhang S; Liu P; Wang J; Du H
Cancer Genet; 2020 Oct; 248-249():25-30. PubMed ID: 32987255
[TBL] [Abstract][Full Text] [Related]
27. Identification of an immune-related RNA-binding protein signature to predict survival and targeted therapy responses in liver cancer.
Yang S; Lin S; Liu K; Liu Y; Xu P; Zheng Y; Deng Y; Zhang D; Zhai Z; Li N; Ren X; Dai Z; Kang H
Genomics; 2021 Mar; 113(2):795-804. PubMed ID: 33524497
[TBL] [Abstract][Full Text] [Related]
28. APOBEC: A molecular driver in cervical cancer pathogenesis.
Revathidevi S; Murugan AK; Nakaoka H; Inoue I; Munirajan AK
Cancer Lett; 2021 Jan; 496():104-116. PubMed ID: 33038491
[TBL] [Abstract][Full Text] [Related]
29. Prevalence and distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia in China: a meta-analysis.
Zhang J; Cheng K; Wang Z
Arch Gynecol Obstet; 2020 Dec; 302(6):1329-1337. PubMed ID: 32914222
[TBL] [Abstract][Full Text] [Related]
30. LUM Expression and Its Prognostic Significance in Gastric Cancer.
Chen X; Li X; Hu X; Jiang F; Shen Y; Xu R; Wu L; Wei P; Shen X
Front Oncol; 2020; 10():605. PubMed ID: 32500021
[No Abstract] [Full Text] [Related]
31. GSEA-assisted gene signatures valid for combinations of prognostic markers in PCNSL.
Takashima Y; Hamano M; Fukai J; Iwadate Y; Kajiwara K; Kobayashi T; Hondoh H; Yamanaka R
Sci Rep; 2020 May; 10(1):8435. PubMed ID: 32439996
[TBL] [Abstract][Full Text] [Related]
32. miR-499 rs3746444 and miR-196a-2 rs11614913 Are Associated with the Risk of Glioma, but Not the Prognosis.
Yang S; Zheng Y; Zhou L; Jin J; Deng Y; Yao J; Yang P; Yao L; Wu Y; Zhai Z; Li N; Lyu L; Dai Z
Mol Ther Nucleic Acids; 2020 Dec; 22():340-351. PubMed ID: 33230439
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
[TBL] [Abstract][Full Text] [Related]
34. HPV Vaccination and the Risk of Invasive Cervical Cancer.
Lei J; Ploner A; Elfström KM; Wang J; Roth A; Fang F; Sundström K; Dillner J; Sparén P
N Engl J Med; 2020 Oct; 383(14):1340-1348. PubMed ID: 32997908
[TBL] [Abstract][Full Text] [Related]
35. HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers.
Ren S; Gaykalova DA; Guo T; Favorov AV; Fertig EJ; Tamayo P; Callejas-Valera JL; Allevato M; Gilardi M; Santos J; Fukusumi T; Sakai A; Ando M; Sadat S; Liu C; Xu G; Fisch KM; Wang Z; Molinolo AA; Gutkind JS; Ideker T; Koch WM; Califano JA
Oncogene; 2020 Oct; 39(40):6327-6339. PubMed ID: 32848210
[TBL] [Abstract][Full Text] [Related]
36. Screening for cervical cancer: Choices & dilemmas.
Rajaram S; Gupta B
Indian J Med Res; 2021 Aug; 154(2):210-220. PubMed ID: 34854432
[TBL] [Abstract][Full Text] [Related]
37. Screening for Cervical Cancer.
Eun TJ; Perkins RB
Med Clin North Am; 2020 Nov; 104(6):1063-1078. PubMed ID: 33099451
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis of a chemokine- and chemokine receptor family-based signature for patients with lung adenocarcinoma.
Fan T; Liu Y; Liu H; Wang L; Tian H; Zheng Y; Zheng B; Xue L; Tan F; Xue Q; Gao S; Li C; He J
Cancer Immunol Immunother; 2021 Dec; 70(12):3651-3667. PubMed ID: 33977344
[TBL] [Abstract][Full Text] [Related]
39. Bioinformatic analysis identifying FGF1 gene as a new prognostic indicator in clear cell Renal Cell Carcinoma.
Zhang X; Wang Z; Zeng Z; Shen N; Wang B; Zhang Y; Shen H; Lu W; Wei R; Ma W; Wang C
Cancer Cell Int; 2021 Apr; 21(1):222. PubMed ID: 33865387
[TBL] [Abstract][Full Text] [Related]
40. Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism-related genes.
Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S
Cancer Cell Int; 2021 Apr; 21(1):219. PubMed ID: 33858449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
